Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer
Open accessThe DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Diabetic men have lowered overall risk of prostate cancer (PCa), but the role of hyperglycaemia is unclear. In this cohort study, we estimated PCa risk among men with diabetic fasting blood glucose level. METHODS: Participants of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC) were linked to laboratory database for information on glucose measurements since 1978. The data were available for 17,860 men. Based on the average yearly level, the men were categorised as normoglycaemic, prediabetic, or diabetic. Median follow-up was 14.7 years. Multivariable-adjusted Cox regression was used to calculate hazard ratios (HRs) and 95% confidence intervals (95% CIs) for prostate cancer overall and separately by Gleason grade and metastatic stage. RESULTS: In total 1,663 PCa cases were diagnosed. Compared to normoglycaemic men, those men with diabetic blood glucose level had increased risk of PCa (HR 1.52; 95% CI 1.31-1.75). The risk increase was observed for all tumour grades, and persisted for a decade afterwards. Antidiabetic drug use removed the risk association. Limitations include absence of information on lifestyle factors and limited information on BMI. CONCLUSIONS: Untreated diabetic fasting blood glucose level may be a prostate cancer risk factor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“There is evidence of an association of obesity and high-grade aggressive prostate cancers.1758”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1758]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Zappa, M., Nelen, V., Kwiatkowski, M., Lujan, M., Määttänen, L., Lilja, H., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60525-0 · Cited by 1,566
Self-citationData Quality and Quality Control of a Population-Based Cancer Registry: Experience in Finland
Teppo, L., Pukkala, E., & Lehtonen, M. (1994) · Acta Oncologica · doi:10.3109/02841869409098430 · Cited by 642
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
Coyle, C., Cafferty, F. H., Vale, C., & Langley, R. E. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw410 · Cited by 452
Diabetes mellitus and risk of prostate cancer: a meta-analysis
Bonovas, S., Filioussi, K., & Tsantes, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1415-6 · Cited by 327
Prospective Study of Fruit and Vegetable Intake and Risk of Prostate Cancer
Kirsh, V. A., Peters, U., Mayne, S. T., Subar, A. F., Chatterjee, N., Johnson, C. C., & Hayes, R. B. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm065 · Cited by 286
Hyperinsulinaemia: A prospective risk factor for lethal clinical prostate cancer
Hammarsten, J., & Högstedt, B. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.09.003 · Cited by 214
Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Prostate Cancer
Albanes, D., Weinstein, S. J., Wright, M. E., Männistö, S., Limburg, P. J., Snyder, K., & Virtamo, J. R. K. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp260 · Cited by 155
Bylsma, L. C., & Alexander, D. D. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0111-3 · Cited by 130
Does cancer risk increase with HbA1c, independent of diabetes?
de Beer, J. C., & Liebenberg, L. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.150 · Cited by 125
Prostate Cancer Mortality in the Finnish Randomized Screening Trial
Kilpeläinen, T. P., Tammela, T. L. J., Malila, N. K., Hakama, M., Santti, H., Määttänen, L., Stenman, U., Kujala, P. M., & Auvinen, A. P. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt038 · Cited by 112
Self-citation
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Application of support vector machine algorithm for early differential diagnosis of prostate cancer
Akinnuwesi, B. A., Olayanju, K. A., Aribisala, B. S., Fashoto, S. G., Mbunge, E., Okpeku, M., & Owate, P. (2022) · Data Science and Management · doi:10.1016/j.dsm.2022.10.001 · Cited by 70
Cancer Progress and Priorities: Prostate Cancer
Kensler, K. H., & Rebbeck, T. R. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0412 · Cited by 75
Energy Restriction and Colorectal Cancer: A Call for Additional Research
Castejón, M., Plaza, A., Martinez-Romero, J., Fernandez-Marcos, P. J., de Cabo, R., & Diaz-Ruiz, A. (2020) · Nutrients · doi:10.3390/nu12010114 · Cited by 51
Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank
Monroy‐Iglesias, M. J., Russell, B. A., Crawley, D., Allen, N. E., Travis, R. C., Perez‐Cornago, A., Hemelrijck, M. V., & Beckmann, K. (2020) · International Journal of Cancer · doi:10.1002/ijc.33255 · Cited by 48
Metadata
- Authors
- Murtola, T. J., Vihervuori, V. J., Lahtela, J., Talala, K., Taari, K., Tammela, T. L., & Auvinen, A.
- Affiliations
- Tampere University (FI)
- Tampere University Hospital (FI)
- Finnish Cancer Registry (FI)
- Helsinki University Hospital (FI)
- University of Tampere (FI)
- Corresponding author
- Murtola, Teemu J.
- ORCID
- Venue
- British Journal of Cancer
- Published
- 2018-03-22
- Volume
- 118
- Issue
- 9
- Pages
- 1248-1254
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC5943324
- OpenAlex
- W2792056645
- Cited by
- 28
- References
- 31
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 2
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- British Journal of Cancer (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Tampere University Institutional Repository (Tampere University) (acceptedVersion)
- Työväentutkimus Vuosikirja (submittedVersion, other-oa)
- Tampere University Institutional Repository (Tampere University) (submittedVersion)
- Funders
- Pirkanmaan Sairaanhoitopiiri (150640)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- prostate cancer, fasting blood glucose, hyperglycemia, diabetes mellitus, glycemic control, prediabetes, prostate cancer risk factors, Gleason grade, metastatic prostate cancer, antidiabetic drug use
- MeSH terms
- Aged, Blood Glucose, Diabetes Mellitus, Type 2, Fasting, Finland, Humans, Hyperglycemia, Hypoglycemic Agents, Male, Mass Screening, Middle Aged, Prostatic Neoplasms, Registries, Risk Factors, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer. https://app.cochat.ai/papers/10.1038/s41416-018-0055-4
- The paper
- Murtola, T. J., Vihervuori, V. J., Lahtela, J., Talala, K., Taari, K., Tammela, T. L., & Auvinen, A. (2018). Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer. British Journal of Cancer. https://doi.org/10.1038/s41416-018-0055-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.